acetylglucosamine has been researched along with Obesity in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.85) | 29.6817 |
2010's | 11 (42.31) | 24.3611 |
2020's | 14 (53.85) | 2.80 |
Authors | Studies |
---|---|
Farrar, MA; Hogquist, KA; Liu, B; Moazzami, Z; Ruan, HB; Salgado, OC; Zhang, Z | 1 |
Cha, KH; Choi, JS; Jung, M; Kim, DJ; Kim, J; Kim, M; Ko, G; Lee, G; Lee, Y; Park, JM; Si, J; Sung, J; Vázquez-Castellanos, JF; Yoon, HS; Yoon, S; You, HJ; Yu, J | 1 |
Fujita, Y; Ida, S; Kume, S; Maegawa, H; Morino, K; Nakamoto, A; Ohashi, N; Perry, RJ; Sakuma, I; Shulman, GI; Sugawara, L; Ugi, S; Yanagimachi, T | 1 |
Abo, H; Denning, TL; Harusato, A; Imura, T; Kawashima, H; Muraki, A; Suzuki, M; Takahashi, K | 1 |
Aouadi, M; Arner, P; Bergo, MO; Checa, A; Choudhury, RP; Dollet, L; Douagi, I; Edgar, L; Gao, H; Krook, A; Laurencikiene, J; Lecoutre, S; McCarthy, M; Petrus, P; Rooyackers, O; Rydén, M; Sulen, A; Tavira, B; Wheelock, CE; Wiel, C | 1 |
Fu, M; Li, MD; Liu, Y; Mi, J; Ni, W; Ong, Q; Wang, S; Yang, X; Yang, Y; Zhang, B; Zhang, K | 1 |
Bagul, HP; Budnar, S; Chakraborty, A; Chattopadhyay, T; Kamat, SS; Kolthur-Seetharam, U; Maniyadath, B; Rajendran, A; Shukla, A; Shukla, N | 1 |
Houttu, N; Koivuniemi, E; Laitinen, K; Mokkala, K; Nielsen, HB; Sørensen, N | 1 |
Albuquerque, JP; Chung, D; Fu, M; Li, R; Li, X; Li, Z; Liu, Y; Luan, HH; Munk, A; Nam, JH; Ong, Q; Perry, RJ; Robert, ME; Shulman, GI; Wang, Q; Wang, S; Yang, X; Yang, Y; Zhang, B; Zhang, D; Zhang, K | 1 |
Gomeshtapeh, FI; Tian, JL | 1 |
Aimaretti, G; Bicchi, C; Cialiè Rosso, M; Collino, M; Cordero, C; Liberto, E; Mai, S; Marzullo, P; Mele, C; Reichenbach, SE; Squara, S; Stilo, F | 1 |
Gao, F; Jiang, T; Jin, L; Li, C; Liu, B; Qin, X; Zheng, Q | 1 |
Fields, PE; Qiang, A; Slawson, C | 1 |
Ameneiro, C; Beiroa, D; Bernardo, G; Bilbao, J; Bravo, SB; Carneiro, C; Cho, JW; Coppari, R; Cuñarro, J; Da Silva Lima, N; Dieguez, C; Dp Chantada-Vazquez, M; Fernandez, U; Fernández-Ramos, D; Ferno, J; Fidalgo, M; Fondevila, MF; Fruhbeck, G; Garcia-Vence, M; Gonzalez-Rellan, MJ; Guallar, D; Herzig, S; Iglesias, C; López, M; Lopitz-Otsoa, F; Martinez-Chantar, ML; Mato, JM; Millet, O; Müller, TD; Nogueiras, R; Novoa, E; Perez-Fernandez, R; Porteiro, B; Rodríguez, A; Sabio, G; Senra, A; Seoane, S; Tovar, S; Varela-Rey, M; Veyrat-Durebex, C; Vidal, A; Woodhoo, A; Yang, WH | 1 |
Katakami, N | 1 |
Dubuquoy, C; Dubuquoy, L; El Yazidi-Belkoura, I; Lefebvre, T; Steenackers, A; Vermuse, J; Very, N | 1 |
Ding, S; Erion, DM; Fang, EX; Li, MD; Ni, W; Vera, NB; Wang, S; Xu, T; Yang, X; Yang, Y; Yin, R; Zhang, B; Zhang, K; Zhou, X; Ziso-Qejvanaj, E | 1 |
Cox, EJ; Marsh, SA | 1 |
Bailey, SM; Udoh, US; Young, ME | 1 |
Hanover, JA; Olivier-Van Stichelen, S | 1 |
Choi, JH; Choi, SS; Jang, HJ; Kim, IS; Koh, A; Lee, GH; Lee, H; Lee, YH; Park, D; Ryu, SH; Seo, YK; Suh, PG; Yang, YR | 1 |
Bressan, AF; Chawla, D; Ergul, A; Giachini, FR; Li, W; Lima, VV; Matsumoto, T; Tostes, RC; Webb, RC | 1 |
Aponte, Y; Blackshaw, S; Hart, GW; Hong, I; Huganir, RL; Lagerlöf, O; Slocomb, JE | 1 |
Auvinen, P; Hämäläinen, K; Kosma, VM; Oikari, S; Rilla, K; Tammi, M; Tammi, R; Tiainen, S | 1 |
Asemu, G; Brown, BH; Cox, JW; Essop, MF; Hecker, PA; Kimar, CP; Mapanga, RF; O'Connell, KA; Ribeiro, RF; Shekar, KC; Stanley, WC | 1 |
Christeff, N; Gangneux, N; Issad, T; Kuo, M; Zilberfarb, V | 1 |
5 review(s) available for acetylglucosamine and Obesity
Article | Year |
---|---|
Potential Roles of O-GlcNAcylation in Primary Cilia- Mediated Energy Metabolism.
Topics: Acetylglucosamine; Cilia; Diabetes Mellitus; Energy Metabolism; Homeostasis; Humans; Insulin-Secreting Cells; Obesity; Signal Transduction | 2020 |
The Role of O-GlcNAcylation in Immune Cell Activation.
Topics: Acetylglucosamine; Animals; Diabetes Mellitus; Humans; Immune System; N-Acetylglucosaminyltransferases; Obesity | 2021 |
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
Topics: Acetylglucosamine; Animals; Arteries; Atherosclerosis; Cardiovascular Diseases; Diabetes Complications; Disease Progression; Dyslipidemias; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypertension; Inflammation; Insulin Resistance; Mice; Muscle, Smooth, Vascular; Obesity; Oxidative Stress; Polymers; Protein Kinase C; Quality of Life; Reactive Oxygen Species; Risk Factors | 2018 |
Circadian regulation of metabolism.
Topics: Acetylglucosamine; Adenosine Diphosphate Ribose; Alcohol Drinking; Amino Acids; AMP-Activated Protein Kinases; Animals; Carbohydrate Metabolism; Circadian Clocks; Circadian Rhythm; Diabetes Mellitus; Energy Metabolism; Heme; Homeostasis; Humans; Light; Lipid Metabolism; Mitochondria; NAD; Obesity; Proteins; Sleep; Sleep Disorders, Circadian Rhythm; Suprachiasmatic Nucleus; Wakefulness | 2014 |
You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.
Topics: Acetylglucosamine; Alzheimer Disease; Cardiovascular Diseases; Chromatin; Chronic Disease; Diabetes Mellitus, Type 2; Diet; Epigenesis, Genetic; Feeding Behavior; Female; Gene Expression Regulation; Genetic Loci; Genomic Imprinting; Homeostasis; Humans; Hypothalamo-Hypophyseal System; Lupus Erythematosus, Systemic; N-Acetylglucosaminyltransferases; Neoplasms; Neurogenesis; Obesity; Protein Processing, Post-Translational; X Chromosome Inactivation | 2015 |
21 other study(ies) available for acetylglucosamine and Obesity
Article | Year |
---|---|
An OGT-STAT5 Axis in Regulatory T Cells Controls Energy and Iron Metabolism.
Topics: Acetylglucosamine; Animals; Insulin Resistance; Iron; Mice; N-Acetylglucosaminyltransferases; Obesity; STAT5 Transcription Factor; T-Lymphocytes, Regulatory | 2022 |
Bacteroides vulgatus SNUG 40005 Restores Akkermansia Depletion by Metabolite Modulation.
Topics: Acetylglucosamine; Akkermansia; Animals; Bacteroides; Diet, High-Fat; Humans; Mice; Obesity | 2023 |
Topics: Acetylglucosamine; Adipose Tissue; Animals; Body Weight; Fatty Acids, Nonesterified; Mice; N-Acetylglucosaminyltransferases; Obesity; Weight Gain | 2023 |
N-acetylglucosamine-6-O sulfation on intestinal mucins prevents obesity and intestinal inflammation by regulating gut microbiota.
Topics: Acetylglucosamine; Animals; Gastrointestinal Microbiome; Inflammation; Mice; Mucins; Obesity; Polysaccharides | 2023 |
Glutamine Links Obesity to Inflammation in Human White Adipose Tissue.
Topics: Acetylglucosamine; Adipocytes; Adipose Tissue, White; Adult; Animals; Cells, Cultured; Cohort Studies; Female; Glucose; Glutamine; Glycosylation; Humans; Inflammation; Male; Mice, Inbred C57BL; Middle Aged; N-Acetylglucosaminyltransferases; Obesity | 2020 |
O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesity.
Topics: Acetylglucosamine; Animals; Cell Line, Tumor; Diet; Fasting; Gene Deletion; HEK293 Cells; HeLa Cells; Homeostasis; Humans; Intra-Abdominal Fat; Lipolysis; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; N-Acetylglucosaminyltransferases; Obesity; Perilipin-1; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction | 2020 |
Spatiotemporal gating of SIRT1 functions by O-GlcNAcylation is essential for liver metabolic switching and prevents hyperglycemia.
Topics: Acetylglucosamine; Aging; Animals; Fasting; Gluconeogenesis; Glycosylation; HEK293 Cells; Homeostasis; Humans; Hyperglycemia; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphorylation; Protein Processing, Post-Translational; Sirtuin 1; Spatio-Temporal Analysis | 2020 |
GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile.
Topics: Acetylglucosamine; Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Feces; Female; Fibrinogen; Gastrointestinal Microbiome; Glycoproteins; Haptoglobins; Humans; Inflammation; Metabolomics; Obesity; Pregnancy; Serum Amyloid A Protein | 2020 |
OGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbance.
Topics: Acetylglucosamine; Adipose Tissue; Animals; Humans; Macrophage Activation; Macrophages; Mice; Mice, Knockout; N-Acetylglucosaminyltransferases; Obesity; Phosphorylation; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction | 2020 |
Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry.
Topics: Acetylglucosamine; Algorithms; Amino Acids, Neutral; Chromatography; Chromatography, Gas; Chromatography, High Pressure Liquid; Cyclohexanes; Deoxyribose; Esters; Fuzzy Logic; Gas Chromatography-Mass Spectrometry; Glucuronates; Humans; Lactose; Male; N-Acetylneuraminic Acid; Obesity; Reference Values; Saliva; Solvents; Spectrometry, Mass, Electrospray Ionization; Urea | 2021 |
Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity.
Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Hypoxia; Cell Line; Diazooxonorleucine; Disease Models, Animal; Glycosylation; Humans; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Reperfusion Injury; Myocardium; Obesity; Protein Processing, Post-Translational; Rats | 2021 |
O-GlcNAcylated p53 in the liver modulates hepatic glucose production.
Topics: Acetylglucosamine; Animals; Base Sequence; Caloric Restriction; Cell Line; Colforsin; Diabetes Mellitus, Type 2; Epinephrine; Glucagon; Glucocorticoids; Gluconeogenesis; Glucose; Glycosylation; Hepatocytes; Humans; Hydrocortisone; Hyperglycemia; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Liver; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Promoter Regions, Genetic; Protein Binding; Protein Stability; Pyruvic Acid; RNA, Messenger; Transcription, Genetic; Tumor Suppressor Protein p53 | 2021 |
Cross regulation between mTOR signaling and O-GlcNAcylation.
Topics: Acetylglucosamine; Animals; Colonic Neoplasms; Glycosylation; Mice; Mice, Obese; N-Acetylglucosaminyltransferases; Obesity; Receptor Cross-Talk; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Adipocyte OGT governs diet-induced hyperphagia and obesity.
Topics: Acetylglucosamine; Adipocytes; Adipose Tissue; Animals; Blotting, Western; Body Weight; Cannabinoids; Cell Line; Humans; Hyperphagia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Obesity; Real-Time Polymerase Chain Reaction | 2018 |
Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A/HDAC1/2 complex in the heart.
Topics: Acetylglucosamine; Animals; Blood Glucose; Cardiomegaly; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Exercise Therapy; Gene Expression Regulation; Glycosylation; Histone Deacetylase 1; Histone Deacetylase 2; Mice, Inbred C57BL; Myocardium; N-Acetylglucosaminyltransferases; Obesity; Protein Processing, Post-Translational; Repressor Proteins; RNA, Messenger; Running; Sedentary Behavior; Sin3 Histone Deacetylase and Corepressor Complex; Time Factors | 2013 |
Obesity resistance and increased energy expenditure by white adipose tissue browning in Oga(+/-) mice.
Topics: Acetylglucosamine; Adipocytes, Brown; Adipose Tissue, Brown; Adipose Tissue, White; Animals; beta-N-Acetylhexosaminidases; Blood Glucose; Body Weight; Cell Differentiation; Diabetes Mellitus, Type 2; Energy Metabolism; Glucose Intolerance; Insulin Resistance; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Signal Transduction; Thermogenesis | 2015 |
High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity?
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Cerebral Arteries; Diet, High-Fat; Hyperlipidemias; Male; Mitogen-Activated Protein Kinases; N-Acetylglucosaminyltransferases; Obesity; Phosphorylation; Protein Processing, Post-Translational; Rats, Wistar | 2016 |
The nutrient sensor OGT in PVN neurons regulates feeding.
Topics: Acetylglucosamine; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Energy Metabolism; Feeding Behavior; Gene Deletion; Homeostasis; Hyperphagia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Acetylglucosaminyltransferases; Neurons; Obesity; Paraventricular Hypothalamic Nucleus; Protein Processing, Post-Translational; Satiety Response | 2016 |
High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
Topics: Acetylglucosamine; Adult; Aged; Aged, 80 and over; Biomarkers; Breast Neoplasms; Cell Nucleus; Cytoplasm; Female; Glycosylation; Humans; Hyaluronan Synthases; Hyaluronic Acid; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Obesity; Prognosis; Stromal Cells | 2016 |
Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets.
Topics: Acetylglucosamine; Aconitate Hydratase; Adiponectin; Animals; Body Weight; Citrate (si)-Synthase; Diet; Echocardiography; Electrophoresis, Polyacrylamide Gel; Female; Fructose; Glucose Tolerance Test; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Gonads; Heart; Humans; Insulin; Leptin; Mice; Mice, Inbred C3H; Obesity; Oxidative Stress; Triglycerides | 2012 |
[A new mode of reglulation of FoxO1 by O-GlcNAc glycosylation: involvement in the glucotoxicity phenomenon].
Topics: Acetylglucosamine; Diabetes Complications; Forkhead Box Protein O1; Forkhead Transcription Factors; Glucose; Glycogen; Glycolysis; Glycosylation; Hexosamines; Homeostasis; Humans; Models, Biological; Obesity | 2008 |